Sponsor: RedShiftBioIn this GEN webinar, we will discuss some typical workflows used to characterize the properties of vaccines, looking at properties such as particle size, surface charge, aggregation, and protein secondary structure.
Sponsor: Terumo BCTIn this GEN webinar, we will hear from a team of scientists who will discuss the parameters for the fill/finish and cryopreservation steps of a cell therapy manufacturing process. We will also look at data from a typical manual fill and finish process compared to data from an automated process using the Finia® Fill and Finish System.
Sponsor: TriLink BiotechnologiesIn this GEN webinar, Dr. Wen Xue will present a modular delivery strategy for homology-directed repair by combining lipid nanoparticle delivery of Cas9 mRNA with adeno-associated viruses (AAV) encoding a sgRNA and a repair template.
Sponsor: Lonza REGISTER NOW Broadcast Date: June 4, 2020 Time: 8:00 am PT, 11:00 am ET, 17:00 CET In the biopharma industry, there currently is a need to increase...
Sponsor: SartoriusIn this GEN webinar, sponsored by Sartorius, we will hear from two members of the clinical development and discovery research teams at Inovio. We will learn about the novel DNA-encoded monoclonal antibody (dMab™) technology and how it is being employed for cancer therapies. Additionally, our presenters will describe some current pre-clinical work using DNA-encoded immune cell engagers (DICE).
Sponsor: PerkinElmer,In this GEN webinar, sponsored by PerkinElmer, our expert speakers, who are leading investigators in the field of cell and gene therapy, will discuss emerging gene-edited and engineered cell therapies for cancer, as well as the next generation of AAV vectors for human gene therapy.
Please wait while you are redirected to the right page...